Paul Browning, Ph.D., is a first chair litigator focusing on patent litigation and appeals, primarily in the chemical and pharmaceutical areas, including Hatch-Waxman (ANDA) litigation. He has tried cases before judges in various U.S. district courts and has handled arbitrations and mediations. He also advises on patent portfolio strategy with an eye toward success in litigation.
Paul’s broad litigation experience includes taking and cross-examining witnesses at trial, briefing and arguing dispositive motions, drafting appellate briefs, and arguing cases on appeal. He has also managed day-to-day litigation activities in actions involving multiple parties. In addition to his litigation practice, Paul advises clients on a variety of patent matters, including strategic development of their patent portfolios and coordination of prosecution and U.S. and foreign litigation strategy and related proceedings before the Patent Trial and Appeal Board.
Paul frequently lectures on various topics in chemical patent law. He designed laser systems and conducted spectroscopy of small molecules while earning master’s and doctorate degrees at the University of Chicago.
Paul devotes a portion of his practice to pro bono matters. He represents military personnel seeking enhanced compensation for injuries received while serving in the military, including injuries received in combat. He also represents veterans in cases before the U.S. Court of Appeals for Veterans Claims and the U.S. Court of Appeals for the Federal Circuit.
- Representing Urovant Sciences GmbH, Sumitomo Pharma America, Inc. and Sumitomo Pharma, Inc. in 4 related Hatch-Waxman litigations concerning Sumitomo Pharma’s Gemtesa® product.
- Represented Otsuka Pharmaceutical Co., Ltd. in 18 related Hatch-Waxman litigations concerning Otsuka’s Rexulti® product.
- Represented Biogen International GmbH in 28 related Hatch-Waxman litigations concerning Biogen’s Tecfidera® product
- Represented Otsuka Pharmaceutical Co., Ltd. in 24 related Hatch-Waxman litigations concerning Otsuka’s Ability® tablet products
- Appellate
- Intellectual Property
- Accounting
- Agriculture
- Aviation
- Automotive
- Banking
- Construction and materials
- Consumer goods and services
- Energy
- Financial services
- Fisheries and aquaculture
- Food and beverage
- Forestry
- Gaming
- Government and public policy
- Healthcare
- Industrials
- Insurance
- Investment management
- Media
- Mining
- Natural resources
- Oil and gas
- Pharmaceutical and life sciences
- Real estate
- Shipping
- Social infrastructure
- Technology and telecommunications
- Tourism
- Transport
- Utilities
- Other
- JD, cum laude, Harvard Law School - 1999
- PhD, Chemistry, University of Chicago - 1996
- MS, Chemistry, University of Chicago - 1993
- BS, Chemistry, magna cum laude, Brown University - 1991
- National Veterans Legal Services Program - 2023
- U.S. Patent and Trademark Office - 2018
- District of Columbia - 2000
- Massachusetts - 1999
- U.S. District Court, D. Massachusetts - 2020
- U.S. Court of Federal Claims - 2015
- Supreme Court of the United States - 2012
- U.S. Court of Appeals, Veterans Claims - 2012
- U.S. Court of Appeals, Eleventh Circuit - 2011
- U.S. Court of Appeals, Federal Circuit - 2010